Jazz Pharmaceuticals GAAP EPS of $6.64 beats by $3.75, revenue of $1.2B beats by $30M

Jazz Pharmaceuticals reported GAAP EPS of $6.64, significantly beating estimates by $3.75, with revenue of $1.2 billion also surpassing expectations by $30 million.